Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-84.63	26.19	-170.40
Graham Fair Price	41.94	0.05	0.03
PEG	-48.03	0.25	-0.49
Price/Book	2.25	0.14	0.14
Price/Cash Flow	-47.77	13.62	26.07
Prices/Earnings	-48.87	25.30	49.48
Price/Sales	-48.87	1.56	3.05
Price/FCF	-47.77	13.62	26.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	67.93	0.46	0.27
Operating Margin	0.00	0.06	0.06
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	99.57
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	0.22	-85.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.07	1.00	-6.82
EPS QOQ	1.02	1.00	-1.61
FCF QOQ	1.38	0.96	-30.44
Revenue QOQ	-0.48	1.00	107.77
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	611.02	409.80	-32.93
Days Sales Outstanding (DSO)	551.01	275.50	-50.00
Inventory Turnover	0.15	0.22	49.10
Debt/Capitalization	0.07	0.07	2.93
Quick Ratio	2.08	-1.06	-48.95
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.27	0.28	0.37
Cash	< 0.005	-0.12	1493.47
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	96.50
Revenue	0.01	0.02	100.74
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.51	4.51	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-42.48	6.66	-84.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating